Ronald Li

Ronald Li is the founder of Medera, Inc., founded in 2014, serving as Chairman & Chief Executive Officer.
Dr. Li is also the founder of Novoheart Holdings Ltd.,Novoheart Holdings, Inc...
Dr. Li is Chief Executive Officer & Director at Xellera Therapeutics Ltd. Dr. Li is Director-Ming Wai Lau Centre at Karolinska Institutet since 2016.
Dr. Li is Director-Stem Cell & Regenerative Medicine at The University of Hong Kong.
Dr. Li is Chief Scientific Officer at Sardocor Corp.
since 2020.
Dr. Li is Professor at Dr. Li Dak-Sum Research Centre.
Dr. Li was Director at Woodrose Ventures Corp.
Dr. Li was Co-Director-Cardiac Tissue & Cell Engineering at Icahn School of Medicine at Mount Sinai.
Dr. Li was Independent Director at Keen Vision Acquisition Corp.
from 2021 to 2024.
Dr. Li was Associate Professor at the University of California, Davis.
Dr. Li was Assistant Professor at The Johns Hopkins University School of Medicine.
Dr. Li earned a doctorate from the University of Toronto.
Dr. Li completed undergraduate studies at The University of Waterloo.